If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
association |
risk factor |
not provided |
total |
342
|
50
|
307
|
137
|
75
|
3
|
1
|
11
|
920
|
Gene and significance breakdown #
Total genes and gene combinations: 69
Gene or gene combination |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
association |
risk factor |
not provided |
total |
APC
|
92
|
3
|
76
|
26
|
23
|
0 |
1
|
0 |
218
|
MSH6
|
44
|
6
|
32
|
28
|
10
|
0 |
0 |
0 |
120
|
MSH2
|
53
|
7
|
27
|
9
|
9
|
0 |
0 |
0 |
105
|
MLH1
|
53
|
14
|
15
|
8
|
4
|
0 |
0 |
0 |
94
|
MUTYH
|
19
|
5
|
16
|
8
|
4
|
0 |
0 |
0 |
49
|
POLE
|
2
|
0 |
12
|
16
|
7
|
0 |
0 |
0 |
37
|
POLD1
|
0 |
0 |
8
|
13
|
11
|
0 |
0 |
1
|
33
|
PALB2
|
1
|
1
|
23
|
2
|
0 |
0 |
0 |
0 |
27
|
PMS2
|
12
|
1
|
7
|
4
|
1
|
0 |
0 |
0 |
25
|
KDR
|
0 |
0 |
14
|
0 |
0 |
0 |
0 |
0 |
14
|
FLT4, LOC126807632
|
0 |
0 |
13
|
0 |
0 |
0 |
0 |
0 |
13
|
AXIN2
|
2
|
0 |
9
|
0 |
1
|
0 |
0 |
0 |
12
|
ATM
|
2
|
1
|
2
|
4
|
2
|
0 |
0 |
0 |
11
|
TP53
|
3
|
2
|
6
|
0 |
0 |
0 |
0 |
0 |
11
|
FGFR3
|
7
|
0 |
3
|
0 |
0 |
0 |
0 |
0 |
10
|
FLT4
|
0 |
0 |
8
|
1
|
0 |
0 |
0 |
0 |
9
|
ATM, C11orf65
|
2
|
0 |
3
|
3
|
0 |
0 |
0 |
0 |
8
|
BUB1B
|
1
|
0 |
7
|
0 |
0 |
0 |
0 |
0 |
8
|
FLCN
|
3
|
1
|
4
|
0 |
0 |
0 |
0 |
0 |
8
|
FLT1
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
7
|
8
|
PIK3CA
|
5
|
0 |
2
|
0 |
0 |
0 |
0 |
0 |
7
|
BRAF
|
5
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
5
|
BRCA2
|
0 |
2
|
2
|
1
|
0 |
0 |
0 |
0 |
5
|
CHEK2
|
0 |
3
|
2
|
0 |
0 |
0 |
0 |
0 |
5
|
BMPR1A
|
0 |
0 |
1
|
3
|
0 |
0 |
0 |
0 |
4
|
CDH1
|
0 |
0 |
4
|
0 |
0 |
0 |
0 |
0 |
4
|
PPARG
|
4
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4
|
SMAD4
|
2
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
4
|
intergenic
|
0 |
0 |
0 |
0 |
0 |
3
|
0 |
0 |
3
|
BARD1
|
0 |
0 |
2
|
1
|
0 |
0 |
0 |
0 |
3
|
CTNNB1, LOC126806658
|
3
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3
|
EPCAM
|
3
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3
|
FLT1, LOC126861720
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3
|
3
|
PTEN
|
0 |
0 |
0 |
3
|
0 |
0 |
0 |
0 |
3
|
STK11
|
0 |
0 |
1
|
2
|
0 |
0 |
0 |
0 |
3
|
BAX
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
BRCA1
|
1
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
2
|
BRIP1
|
0 |
1
|
0 |
0 |
1
|
0 |
0 |
0 |
2
|
EP300
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
MCC
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
PTPRJ
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
RAD51C
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
0 |
2
|
AKT1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
AOPEP, FANCC
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
APC, LOC129994371
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
BCL10
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
BRCA1, LOC126862571
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
BUB1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
DCC
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
DLC1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
FANCE
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
LOC129933707, LOC129933708, MSH6
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
LOC130009266, POLE
|
0 |
0 |
0 |
0 |
1
|
0 |
0 |
0 |
1
|
LOC130062899, STK11
|
0 |
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
MLH3
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
MRE11
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
MT-ND1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
MUTYH, TOE1
|
0 |
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
NBN
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
NRAS
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
PDGFRA
|
0 |
0 |
0 |
0 |
1
|
0 |
0 |
0 |
1
|
PDGFRL
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
PKHD1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
PTPN12
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
RAD51D, RAD51L3-RFFL
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
RAD54B
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
RAD54L
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
REV3L
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
XRCC2
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Submitter and significance breakdown #
Submitter |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
association |
risk factor |
not provided |
total |
Department of Pathology and Laboratory Medicine, Sinai Health System
|
256
|
35
|
174
|
133
|
73
|
0 |
0 |
0 |
671
|
Fulgent Genetics, Fulgent Genetics
|
20
|
3
|
49
|
0 |
2
|
0 |
0 |
0 |
74
|
Immunobiology Lab; University of Kashmir
|
0 |
0 |
35
|
0 |
0 |
0 |
0 |
10
|
45
|
OMIM
|
43
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
43
|
3DMed Clinical Laboratory Inc
|
13
|
0 |
18
|
1
|
0 |
0 |
0 |
0 |
32
|
Leiden Open Variation Database
|
0 |
0 |
19
|
0 |
0 |
0 |
0 |
0 |
19
|
Pathway Genomics
|
8
|
1
|
3
|
1
|
1
|
0 |
0 |
0 |
14
|
Medical Genetics Laboratory, Umraniye Training and Research Hospital, University of Health Sciences
|
10
|
3
|
1
|
0 |
0 |
0 |
0 |
0 |
14
|
Genetic Predisposition to Colorectal Cancer Group, Institut d’Investigacions Biomediques August Pi i Sunyer
|
0 |
6
|
0 |
0 |
0 |
0 |
0 |
0 |
6
|
Centre for Mendelian Genomics, University Medical Centre Ljubljana
|
2
|
0 |
3
|
0 |
0 |
0 |
0 |
0 |
5
|
CSER _CC_NCGL, University of Washington
|
0 |
0 |
2
|
1
|
0 |
0 |
0 |
0 |
3
|
Colorectal Cancer Research Lab, Singapore General Hospital
|
0 |
0 |
0 |
0 |
0 |
3
|
0 |
0 |
3
|
Mendelics
|
0 |
0 |
1
|
1
|
0 |
0 |
0 |
0 |
2
|
Institute of Human Genetics, University of Wuerzburg
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
Cancer Genetics Service, National Cancer Centre Singapore
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
0 |
2
|
KCCC/NGS Laboratory, Kuwait Cancer Control Center
|
1
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
2
|
Genomic Research Center, Shahid Beheshti University of Medical Sciences
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Clinical Genomics Laboratory, Washington University in St. Louis
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Department of Molecular and Medical Genetics, Osaka Medical Center for Cancer and Cardiovascular Diseases
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Rare Disease Group, Clinical Genetics, Karolinska Institutet
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Snyder Lab, Genetics Department, Stanford University
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
0 |
1
|
Medical Genetics Department, and Science and Technology Unit, Umm-al-Qura University
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
GenomeConnect - Invitae Patient Insights Network
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
1
|
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. Neither the University of Utah nor the National
Institutes of Health independently verfies the submitted
information. If you have questions about the information
contained on this website, please see a health care
professional.